JP/ZH: Currently, only the Luminex LTG section and the Service & Support pages regarding Luminex LTG are available in Japanese/Chinese.
19/12/16 - 10:00
Co-optation of a Director (333.18 KB)
10/11/16 - 1:00
DIASORIN GROUP REPORTS CONTINUED GROWTH IN REVENUES AND PROFITABILITY IN THE THIRD QUARTER 2016 (1.05 MB)
02/11/16 - 1:00
DIASORIN LAUNCHES ITS FIRST MOLECULAR TEST WITH THE NEW BUSINESS DIVISION, DIASORIN MOLECULAR: THE NEW SIMPLEXA C. DIFFICILE DIRECT MOLECULAR TEST (141.53 KB)
30/08/16 - 2:00
DiaSorin and Beckman Coulter form strategic partnership to bring the LIAISON XL hepatitis and HIV products to the U.S. market (404.63 KB)
22/08/16 - 2:00
DIASORIN PARTNERS WITH HHS TO FACE THE ZIKA EMERGENCY (158.39 KB)
04/08/16 - 2:00
The Board of Directors approves results for H1'16 (697.16 KB)
28/07/16 - 2:00
DiaSorin starts selling Vitamin D in Japan (724.4 KB)
14/07/16 - 2:00
DiaSorin increases diagnostic test menu for molecular screening of Acute Myeloid Leukemia (278.18 KB)
10/06/16 - 2:00
Weekly report treasury shares buy-back (289.83 KB)
10/06/16 - 2:00
Conclusion buy-back plan (367.77 KB)
07/06/16 - 2:00
DiaSorin launches the new Helicobacter pylori IgG CLIA test (518.61 KB)
03/06/16 - 2:00
Weekly report treasury shares buy-back (290.21 KB)
30/05/16 - 2:00
Notice filing By-Laws and publication operating procedures for loyalty shares (277.79 KB)
27/05/16 - 2:00
Weekly report treasury shares buy-back (289.34 KB)
20/05/16 - 2:00
Weekly report treasury shares buy-back (290.09 KB)
13/05/16 - 2:00
Acquisition of Focus Diagnostics' Molecular and Immunoassay Product Business (350.22 KB)
12/05/16 - 2:00
Start up treasury shares buy-back plan (305.9 KB)
09/05/16 - 2:00
The Board of Directors approves the results for Q1'16 (632.78 KB)
28/04/16 - 2:00
Shareholders' Meeting FY 2015 (365.15 KB)
30/03/16 - 2:00
DiaSorin to acquire Focus Diagnostics' Molecular and Immunoassay Product Business (133.62 KB)
09/03/16 - 1:00
The Board of Directors approves the results for FY'15 (785.08 KB)
11/11/15 - 1:00
The Board of Directors approves the results for Q3'15 (778.06 KB)
09/09/15 - 2:00
DiaSorin launches the two fastest molecular diagnostic tests in the world to detect fulminant leukemias (229.24 KB)
30/07/15 - 2:00
H1'15 Results (777.06 KB)
20/07/15 - 2:00
DiaSorin and Beckman Coulter sign a distribution agreement for China (238.01 KB)
28/05/15 - 2:00
DiaSorin launches the test for Campylobacter (241.86 KB)
12/05/15 - 2:00
The Board of Directors approves the results for Q1'15 (553.96 KB)
12/05/15 - 2:00
DiaSorin presents the 2015-2017 industrial plan (305.81 KB)
29/04/15 - 2:00
DiaSorin - launches the test for Brahms-Sepsis (506.96 KB)
23/04/15 - 2:00
DiaSorin supports the Pinocchio Project (251.16 KB)
22/04/15 - 2:00
The Board of Directors approves the 2015-2017 plan that will be presented at the Investor Day (141.85 KB)
22/04/15 - 2:00
Shareholders' meeting approves FY Results 2014 (105.93 KB)
14/04/15 - 2:00
DiaSorin launches the tests for Bordetella pertussis (187.11 KB)
10/04/15 - 2:00
Investor Day-save the date (107.93 KB)
24/03/15 - 1:00
DiaSorin in aid of Haiti's children in partnership with the Francesca Rava Foundation (504.27 KB)
03/03/15 - 1:00
The Board of Directors approves the results for FY'14 (783.03 KB)
24/02/15 - 1:00
DiaSorin supports Emergency in Sudan (612.64 KB)
13/02/15 - 1:00
DiaSorin teams with FISIP for Progetto talenti (612.64 KB)
14/01/15 - 1:00